- €72.93m
- €70.77m
- €10.97m
Brief: Nexstim To License Technology To Us-Based Medical Technology Company Magnus Medical
Brief: Nexstim Gets NBS 5+ System Order From Customer In U.S.
Brief: Nexstim Receives NBS System Upgrade Order From Finnish Hospital
Brief: Nexstim Receives NBS System Upgrade Order In U.S.
Brief: Nexstim Announces Results Of The Pilot Study In Chronic Pain Treatment At Helsinki University Hospital
Brief: Nexstim Receives Order In Finland
Brief: Nexstim Receives NBS System Order From Hospital In Germany
Brief: Nexstim Agrees On Strategic Investment Into Management Services Organisation
Brief: Nexstim Receives NBS System Order From Hospital In Middle East
Brief: Nexstim Receives Two NBS System Orders From Hospitals In Europe
Brief: Nexstim Gets System Orders From Existing Hospital Customers In Finland
Brief: Nexstim Announces Continuation Of Pilot Study In Treatment Of Severe Depression At Kuopio University Hospital
Brief: Nexstim H1 Operating Loss Narrows To EUR 0.9 Mln
Brief: Nexstim H1 Oper Loss Narrows To EUR 0.9 Mln
Brief: Nexstim Receives Order From The Medical University Of South Carolina
Brief: Nexstim Gets Order From New Customer In The U.S.
Brief: Nexstim Gets Order From University Hospital In Germany
Brief: Nexstim Gets Order From University Hospital In Finland
Brief: Nexstim Updates On Pilot Study In Chronic Pain Treatment At Helsinki University Hospital